India, March 13 -- The Government of India has issued a release:
As informed by Ministry of Health & Family Welfare, many of the drugs required for the treatment of rare diseases are expensive as they are imported from outside the country. National Policy for Rare Diseases 2021 (NPRD, 2021) facilitates financial and medical support of up to Rs. 50 Lakh per patient for treatment of any of the 63 identified rare diseases through 15 designated Centres of Excellence.
Further, the Union Cabinet on 24.02.2021 has approved Production Linked Incentive (PLI) Scheme for Pharmaceuticals with the objective to enhance India's manufacturing capabilities by increasing investment and production in the pharmaceuticals sector and contributing to product di...